Italian database study for parathyroid cancer or atypical adenoma
Part of Cancer, Hormones & metabolism clinical trials.
This study is building a database of patients with parathyroid carcinoma or atypical parathyroid adenoma. By gathering information, doctors hope to learn more about these rare tumors and improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with parathyroid carcinoma (a rare cancer of the parathyroid gland).
- Or you must have been diagnosed with an atypical parathyroid adenoma (a noncancerous but unusual growth of the parathyroid gland).
- You can join if you have either one of these conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and/or tissue samples from people with parathyroid problems to better understand different types of parathyroid tumors. It does not test a new medicine—instead, researchers analyze samples to learn what makes each tumor type different.
This study is creating a database of people with hypoparathyroidism or pseudohypoparathyroidism in Italy. It may help researchers learn more about these conditions and improve future care.
This is an observational study that follows people who have or may develop parathyroid-related conditions. The goal is to better understand how these problems change over time and what patterns show up, which can help improve future care.
This study looks at the genetic makeup of parathyroid tumors in people with hyperparathyroidism. It aims to understand why these tumors form and how they behave, which could help improve treatment decisions.
This study collects information from people who have been diagnosed with thyroid cancer. It helps researchers understand thyroid cancer and may support future research or treatments.
This trial is creating a registry (a database) for people with parathyroid disease. It will collect information to help doctors better understand and treat these conditions.
Hear when a new Parathyroid Gland Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.